In crescentic IgA nephropathy, fractional excretion of IgG in combination with nephron loss is the best predictor of progression and responsiveness to immunosuppression

Clinical Journal of the American Society of Nephrology

Volumn 4, Issue 5, 2009, Pages 929-935

  Bazzi, Claudio ^a   Rizza, Virginia ^a   Raimondi, Sara ^b   Casellato, Daniela ^a   Napodano, Pietro ^a   D'Amico, Giuseppe ^a  

^a SAN CARLO BORROMEO HOSPITAL   (Italy)

^b EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 MACROGLOBULIN; ALPHA 2 MACROGLOBULIN; CREATININE; CYCLOPHOSPHAMIDE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; MACROGLOBULIN; STEROID; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; IMMUNOSUPPRESSIVE AGENT;

ADULT; AREA UNDER THE CURVE; ARTICLE; CELL LOSS; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE URINE LEVEL; DISEASE COURSE; FEMALE; HISTOLOGY; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; KIDNEY DISEASE; MALE; NEPHRON; PROTEINURIA; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; SURVIVAL RATE; TREATMENT RESPONSE; URINARY EXCRETION; BIOPSY; BLOOD; FOLLOW UP; IMMUNOGLOBULIN A NEPHROPATHY; IMMUNOLOGY; MIDDLE AGED; MORTALITY; PATHOLOGY; PREDICTION AND FORECASTING; PROPORTIONAL HAZARDS MODEL; RISK FACTOR; URINE;

ADULT; ALPHA-MACROGLOBULINS; BIOLOGICAL MARKERS; BIOPSY; CREATININE; CYCLOPHOSPHAMIDE; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; GLOMERULONEPHRITIS, IGA; HUMANS; IMMUNOGLOBULIN G; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; NEPHRONS; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; PROTEINURIA; RISK FACTORS; SENSITIVITY AND SPECIFICITY; STEROIDS;

EID: 68549140397     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.05711108     Document Type: Article

References (20)

1. Tumlin JA, Hennigar RA: Clinical presentation, natural history and treatment of crescentic proliferative IgA nephropathy. Semin Nephrol 24: 256-268, 2004
2. D'Amico G: Natural history of idiopathic IgA nephropathy and factors predictive of disease outcome. Semin Nephrol 24: 179-196, 2004
3. Roccatello D, Ferro M, Coppo R, Giraudo G, Quattrocchio G, Piccoli G: Report of intensive treatment of extracapillary glomerulonephritis with focus on crescentic IgA nephropathy. Nephrol Dial Transplant 10: 2054-2059, 1995
4. Goumenos D, Ahuja M, Shortland JR, Brown B: Can immunosuppressive drugs slow the progression of IgA nephropathy? Nephrol Dial Transplant 10: 1173-1181, 1995
5. Harper L, Ferreira MA, Howie AJ, Savage CO, Richards NT, Michael J, Adu D: Treatment of vasculitic IgA nephropathy. J Nephrol 13: 360-366, 2000
6. Roccatello D, Ferro M, Cesano G, Rossi D, Berutti S, Salomone M, Piccoli G, Sena LM: Steroid and cyclophosphamide in IgA nephropathy. Nephrol Dial Transplant 15:833-835, 2000
7. D'Amico G, Napodano P, Ferrario F, Rastaldi MP, Arrigo G: Idiopathic IgA nephropathy with segmental necrotizing lesions on the capillary wall. Kidney Int 59: 682-692, 2001
8. McIntyre CW, Fluck RJ, Lambie SN: Steroid and cyclophosphamide therapy for IgA nephropathy associated with crescenteric change: An effective treatment. Clin Nephrol 56: 193-198, 2001
9. Tumlin JA, Lohavichan V, Hennigar R: Crescentic proliferative IgA nephropathy: Clinical and histological response to methylprednisolone and intravenous cyclophosphamide. Nephrol Dial Transplant 18: 1321-1329, 2003
10. Cattran D: Management of membranous nephropathy: When and what for treatment. J Am Soc Nephrol 16: 1188-1194, 2005
11. D'Amico G, Ferrario F, Colasanti G, Ragni A, Bestetti Bosisio M: IgA-mesangial nephropathy (Berger's disease) with rapid decline in renal function. Clin Nephrol 16: 251-257, 1981
12. Bazzi C, Petrini C, Rizza V, Napodano P, Paparella M, Arrigo G, Pisano L, D'Amico G: Fractional excretion of IgG predicts renal outcome and response to therapy in primary focal segmental glomerulosclerosis: A pilot study. Am J Kidney Dis 41: 328-335, 2003
13. Zweig MH, Campbell G: Receiver-operating characteristic (ROC) plots: A fundamental evaluation tool in clinical medicine. Clin Chem 39: 561-577, 1993
14. Bazzi C, Petrini C, Rizza V, Arrigo G, Beltrame A, Pisano L, D'Amico G: Urinary excretion of IgG and α1-microglobulin predicts clinical course better than extent of proteinuria in membranous nephropathy. Am J Kidney Dis 38: 240-248, 2001
15. Bazzi C, Petrini C, Rizza V, Arrigo G, D'Amico G: A modern approach to selectivity of proteinuria and tubulointerstitial damage in nephrotic syndrome. Kidney Int 58: 1732-1741, 2000
16. Mezzano SA, Droguett MA, Burgos ME, Ardiles LG, Aros CA, Caorsi I, Egido J: Overexpression of chemokines, fibrogenic cytokines, and miofibroblast in human membranous nephropathy. Kidney Int 57: 147-158, 2000
17. Wang Y, Chen J, Chen L, Tay YC, Rangan GK, Harris DC: Induction of monocyte chemoattractant protein-1 in proximal tubule cells by urinary proteins. J Am Soc Nephrol 8: 1537-1545, 1997
18. Zoja C, Donadelli R, Colleoni S, Figliuzzi M, Bonazzola S, Morigi M, Remuzzi G: Protein overload stimulates RANTES production by proximal tubular cells depending on NF-kappaB activation. Kidney Int 53: 1608-1615, 1998
19. Donadelli R, Zanchi C, Morigi M, Buelli S, Batani C, Tomasoni S, Corna D, Rottoli D, Benigni A, Abbate M, Remuzzi G, Zoja C: Protein overload induces fractalkine upregulation in proximal tubular cells through nuclear factor kappaB- and p38 mitogen-activated protein kinase-dependent pathways. J Am Soc Nephrol 14: 2436-2446, 2003
20. Bazzi C, Rizza V, Paparella M, Casellato D, Napodano P, Olivieri G, D'Amico G: Fractional urinary excretion of IgG is the most powerful predictor of reno-protection by ACE-inhibitors in IgA nephropathy. J Nephrol 2009 (in press)